Research Grants And Agreements |
12 Months Ended |
---|---|
Dec. 31, 2019 | |
Research Grants And Agreements [Abstract] | |
Research Grants And Agreements | 7. Research Grants and Agreements Sponsored Research Agreement The Company entered into a Sponsored Research Agreement (SRA) with ODURF during 2014 pursuant to which the Company sponsors research activities performed by ODURF’s Frank Reidy Center. ODURF is compensated by the Company for its conduct of each study in accordance with the budget and payment terms set forth in the applicable task order. During the years ended December 31, 2019, 2018 and 2017, the Company agreed to sponsor $0.8 million, $0.8 million and $0.7 million, respectively, in research during the subsequent 12-month period to be funded through monthly payments made upon ODURF certifying, to the Company’s reasonable satisfaction, that ODURF has met its obligations pursuant to the specified task order and statement of work. The principal investigator may transfer funds with the budget as needed without the Company’s approval so long as the obligations of ODURF under the task order and statement of work remain unchanged and unimpaired. As of December 31, 2019, $0.6 million remained payable under this research agreement. In addition, during the year ended December 31, 2017, the Company agreed to provide $0.3 million in research funding to researchers affiliated with ODURF and EVMS matching funds made available to those researchers by the Virginia Biosciences Health Research Corporation. The Company’s sponsorship affords access to certain intellectual property, if any, developed during the project. As of December 31, 2019, no amount remained payable under this agreement. During the years ended December 31, 2019, 2018 and 2017, the Company incurred costs relating to the SRA equal to $0.9 million, $0.7 million and $0.8 million, respectively.
|